ConsortiEX Inc. Receives State Incentives To Expand Operations In Milwaukee, Wisconsin
10/10/2014
As an incentive, the firm received a $250,000 loan from the Wisconsin Economic Development Corporation. The WEDC Technology Development Loan will be used to help it ramp up product deployment and increase sales, an effort that could create up to 77 new jobs over the next three years, according to state economic development officials . ConsortiEX already is working with several Wisconsin hospitals and a number of other renowned health-care providers across the U.S.
WEDC also granted the company Qualified New Business Venture certification, which makes investors in startup and early-stage companies eligible for a 25 percent tax credit on the amount they invest in the business.
“WEDC is pleased that ConsortiEX is able to utilize two of our invest programs to help the company get off the ground,” said Reed Hall, secretary/CEO of WEDC, the state’s lead economic development organization. “This is a great example of how the state, the private sector and the health-care community are working together to address a serious issue.”
“The state of Wisconsin and Governor Walker’s administration are to be commended for creating a business environment that attracts innovation and enterprise,” said Neal Long, ConsortiEX Founder/CEO. “We’re really looking forward to launching and growing in Wisconsin.”
ConsortiEX was founded in May 2013 in response to a request from the University of Wisconsin Health System’s Pharmacy Department to develop a way to safely distribute sterile injectable compound pharmaceuticals to other hospitals throughout the state. ConsortiEX’s software is expected to improve patient safety, reduce costs and increase the available supply of compounded pharmaceuticals.
“Our administration has laid the groundwork to attract high-tech life science firms like ConsortiEX to Wisconsin,” said Lt. Gov. Rebecca Kleefisch, who met with company officials this week in Madison. “Not only does ConsortiEX have the potential to improve access to life-saving medications, but also to help lower health-care costs and create dozens of family-supporting jobs in the Milwaukee area.”
Project Announcements
Eli Lilly and Company Expands Lebanon, Indiana, Operations
10/09/2024
Johnson & Johnson Plans Wilson, North Carolina, Pharmaceutical Manufacturing Operations
10/08/2024
O’Neal Manufacturing Services Plans Kingsport Tennessee, Steel Fabrication Operations
10/07/2024
Germany-Based ZEISS Expands Chesterfield, Missouri, Research-Production Operations
10/04/2024
Piramal Pharma Solutions Expands Lexington, Kentucky, Operations
10/04/2024
G&H Decoys Plans Corning, Arkansas, Headquarters-Manufacturing Operations
10/04/2024
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Cold Storage: The Next Big Thing in Industrial Real Estate
Q3 2024
-
What the Latest EPA PFAS Rule Means for Site Due Diligence
Q3 2024
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
Mitigating Site Risks for Industrial Projects
Q3 2024
-
The Challenge of Securing Sufficient Electrical Power for Battery Cell Plants
Q3 2024